Does Wyoming Medicaid Cover Wegovy or Zepbound? The Sleep Apnea, MASH and Heart Routes

No. As of November 2026, Wyoming Medicaid has no route for Wegovy or Zepbound as weight-loss drugs: its pharmacy manual excludes anorexiant products from every Medicaid plan, and its drug list names the two medicines only for other conditions.^[1][3] With prior authorization it covers three narrower uses: Zepbound when an adult with obesity has moderate to severe sleep apnea, Wegovy for the liver disease MASH, and Wegovy for adults with a BMI of 27 or more and a past heart attack, stroke or artery disease.^[1][2]

Will Wyoming Medicaid pay for Wegovy or Zepbound to lose weight?

We found no way to get them covered for weight alone. The manual’s list of drugs excluded from all Medicaid plans opens with anorexiant products, and the drug list puts Wegovy and Zepbound only under sleep apnea, MASH and heart-risk criteria.^[1][2][3] Under federal Medicaid law, a state may leave out drugs used for weight loss, and Wyoming takes that option.^[7] Our page on which states’ Medicaid programs pay for Zepbound sets Wyoming beside the rest.

Wyoming runs its drug benefit directly, with OptumRx handling claims and prior authorization. That arrangement took over on April 15, 2026, when claims and requests moved to new OptumRx systems.^[4]

When does Wyoming Medicaid cover a GLP-1?

In four situations. Wyoming’s written criteria are short, often a single sentence, which leaves fewer boxes to tick than in most states.^[1][2]

Does Wyoming Medicaid cover Zepbound for sleep apnea?

Yes. The person must be an adult with obesity and moderate to severe sleep apnea, with an AHI (apnea-hypopnea index) above 15 on a sleep study from the past 12 months.^[1] The criteria say “greater than 15,” so a score of exactly 15 does not meet the letter of the rule even though it is the usual floor for moderate disease. A prescriber whose patient scores right at the line should expect questions.

The text asks for nothing else at the start: no CPAP trial, no sleep specialist, no stated BMI number beyond obesity, and no diabetes exclusion.^[1][2] That is close to the label, which covers moderate to severe sleep apnea in adults with obesity.^[8] Neighboring Montana is much stricter and turns Zepbound down if CPAP alone brings the AHI under 15, as our Montana Medicaid guide explains.

Renewals carry the weight. A new authorization is needed at six months showing at least 5% weight loss, and again at 12 months with a repeat sleep study showing the apnea has improved; later approvals need continued gains in weight and overall health.^[1][2] Booking the follow-up sleep study early avoids a gap in supply. The trials behind the indication are covered in our guide to Zepbound for obstructive sleep apnea.

Will Wyoming Medicaid cover Wegovy for fatty liver disease (MASH)?

Yes, and the requirement is a single line: Wegovy injections need a diagnosis of MASH.^[1] Both the standard Wegovy pens and Wegovy HD sit in the preferred column for MASH, and Rezdiffra is non-preferred.^[1] The change took effect with the January 1, 2026 drug list.^[5]

Wyoming’s text names no fibrosis stage, test or specialist.^[1] The label is narrower than that: it covers noncirrhotic MASH with moderate to advanced fibrosis, stages F2 to F3, under accelerated approval.^[9] A file that shows the stage, from a biopsy, a FibroScan or a similar test, matches the label and is harder to question. Our page on GLP-1 drugs for MASH covers what the trial showed.

Does Wyoming Medicaid cover Wegovy for heart disease?

Yes. The drug list points to the state’s clinical criteria chart for the heart route, and the June 8, 2026 chart asks for a BMI from 27 up plus heart or vessel disease, which it defines as a past heart attack, a past stroke or peripheral artery disease.^[1][2] The chart sets no diabetes exclusion, no A1C limit and no specialist, unlike several nearby states. Nebraska, for example, limits its heart route to adults without diabetes.

Those terms track the label, which covers adults with established heart disease and either obesity or overweight.^[9] The January 2026 drug list notice described Wegovy as preferred with clinical criteria that match its approved uses.^[5]

What does Wyoming require for Ozempic and other diabetes GLP-1s?

A type 2 diabetes patient on Wyoming Medicaid usually needs a 90-day supply of metformin in the past year first; the step is dropped when the patient has atherosclerotic heart disease or risk factors for it.^[1] The preferred drugs are the Ozempic tablet, Rybelsus, Trulicity, brand Victoza and exenatide.^[1]

The Ozempic pen is the surprise. It sits in the non-preferred column, as it has on every 2026 list, so it needs a 90-day failed trial of a preferred drug first; Mounjaro is non-preferred too.^[1] The Ozempic tablet moved into the preferred column on the June 2026 list.^[1]

How does a prescriber file, and how do you appeal?

Wyoming has no GLP-1 form; requests go on the general prior authorization forms listed on the state site.^[12] The OptumRx line for prior authorization, pharmacy appeals and clinical calls is 877-207-1126, and the fax, open around the clock, is 866-964-3472.^[3][6]

If a request is denied, the patient or prescriber can ask for reconsideration within 20 business days of receiving the denial, sending any added records to OptumRx.^[3] Only after the state’s pharmacy program rules on that request can the patient ask for an administrative hearing, and missing the reconsideration window closes that door.^[3] Our walkthrough of how to appeal a GLP-1 denial covers what to send, and the Wyoming state page collects the state’s facts in brief.

What can you do if Wyoming Medicaid will not pay?

Manufacturer savings cards will not help, since Lilly’s terms rule out people on Medicaid and other public coverage.^[10] Cash prices in the figures we track are $349 a month for most Wegovy pen doses through Novo Nordisk, and $299 at the starting dose, $399 at 5 mg and $449 at higher doses refilled on time for Lilly’s Zepbound.^[10][11] Read each program’s terms on government coverage before you enroll. Our roundup of the cheapest ways to pay for a GLP-1 without insurance compares the options.